{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02351232","recordId":"NCT02351232","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02351232-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02351232.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02351232.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-01-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-01-29","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"1d517974671b067b5f1510bf85a1bb491e85ceb08a5934b9bb23edf4806c7b26","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-02-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-02-10","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"c1921100e66b9b625da1ad7d1f8cea809aaa8c3dc5c753d0a9e4f72ff336a8a2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2015-02-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2015-02-24","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"ac75ac5ab48d503adeb27e2d4113bc81cb460eb6736897aea15370a59fd31607","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-03-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-03-03","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"b1790fb9da0bba98e01893eca405560e03975c235248626c948c781a4a4a786d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2016-05-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-05-19","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"b437c2051fee3f6e1a2f7536116f2d5eb4f7e5edf1a6b81cade066c2c389bc16","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2016-10-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2016-10-20","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"fd4de7a40a38b70390ec79b1aca962c4a2cd29f32e52ff269155f43be1fda984","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["References","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2020-02-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2020-02-10","publishedAt":"2026-08-23","recordId":"NCT02351232","recordSha256":"72f4bcae7e76f8dd47200c7dc9aded8687d2834c2161a74a49b1528fd94b4e34","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351232?a=7&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"1afc25841859b97b4399172bb198d93960a9eb84482782af1a8e0d49326f09b2"}}